Skip to content
Screener

Vericel VCEL Q2 2026 earnings

Reported July 30, 2026 · Before market open

Revenue$77.5MBeat by $4.8M
EPS$0.04Beat by $0.07
Revenue estimate$72.7M
EPS estimate-$0.03

Next report

Nov 5, 2026 (in a month)
Revenue estimate$78.0M
EPS estimate$0.02

Financials

Q2 2026

Income statement

See full
Revenue$77.5M+22.5%
Gross profit$56.4M+21.0%
Operating income$434.0K+121%
Net income$2.2M+499%
EPS (diluted)$0.04+500%

Balance sheet

See full
Cash & equivalents$125.4M+55.7%
Total debt$93.1M-7.3%
Total equity$370.0M+20.6%
Total assets$502.9M+15.4%

Cash flow

See full
Operating cash flow$16.2M+97.1%
CapEx$1.9M-76.2%
Free cash flow$14.3M+17,504%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$2.02B+27.0%
Enterprise value$1.99B+25.1%
P/E83.4×-38.2×
P/S6.6×+0.4×

Profitability

See full
Gross margin74.6%+1.1pp
Operating margin6%+5.5pp
Net margin7.9%+5.1pp
FCF margin20.1%—

Returns & leverage

See full
Return on equity7.2%+4.6pp
Debt / equity0.3×-0.1×
Current ratio5×+0.1×

Segments

By product

See full
M A C I Implants and kits$65.5M+22.5%
MACI implants, kits, and instruments$49.9M+26.5%
Epicel$10.4M+20.8%
Biopsy kits$614.0K-4.4%

FAQ

When did Vericel report Q2 2026 earnings?
Vericel (VCEL) reported Q2 2026 earnings on July 30, 2026 before market open.
What were Vericel's Q2 2026 revenue and EPS?
Vericel reported revenue of $77.5M and eps of $0.04 for Q2 2026.
Did Vericel beat estimates in Q2 2026?
Revenue beat the consensus estimate of $72.7M by $4.8M. EPS beat the consensus estimate of $-0.03 by $0.07.
How did Vericel's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.5% from $63.2M a year earlier.
Where can I find Vericel's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-050815) and the 10-Q periodic report (0001628280-26-050836) directly on SEC EDGAR. The filing index links above go to sec.gov.